Capital Export to acquire a majority stake in Science & BioMaterials.

Synopsis

Capital Export, a venture capital and private equity firm, agreed to acquire a majority stake in Science & BioMaterials, an orthopedic surgery equipment maufacturer. Financial terms were not disclosed.

Principals

target

Science & Biomaterials

bidder

Capital Export

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

elena coluccelli

Managing Partner at Rothschild & Co

Financial Advisor

target

Deals

£ 437 M

Total Value

Bidder Team (1)

jean-mathieu sahy

Founder and CEO at CAPITAL EXPORT SAS

Investor

bidder

Deals

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy